Dear Friends and Colleagues
It is with great excitement that we welcome you to the Congress on Cellular and Humoral Immunotherapy in Autoimmunity (CHIA), held in the beautiful city of Paris, France from September 18-20, 2025.
The field of immunotherapy is evolving rapidly, and this conference serves as a pivotal platform to explore the latest advancements and emerging trends in both cellular and humoral immunotherapies, particularly in their application to autoimmune diseases. Our theme this year focuses on bridging the gap between treatments for haematological malignancies and autoimmune disorders, recognizing the profound overlap and unique challenges within these fields.
Over the days of the congress, we have the privilege of hearing from leading experts, researchers, and clinicians who are pioneering new therapies and treatment approaches. From cutting-edge research presentations to interactive workshops, we aim to foster meaningful discussions around the most recent innovations, challenges, and breakthroughs in immunotherapy.
We are proud to present a robust program featuring renowned speakers, each of whom will share their expertise on topics ranging from immune system modulation to the clinical applications of CAR T-cell therapy and B-cell targeting in autoimmunity. These discussions promise to deepen our understanding and expand the possibilities for more effective and personalized treatments.
Our Sponsorship and Exhibition Prospectus offers a wide range of support opportunities to maximize your visibility in accordance with your marketing strategy, objectives and budget.
If you are interested in exploring your participation as a sponsor and/or exhibitor further, please contact us as soon as possible.
We look forward to partnering with you on the CHIA Congress in Paris.
Warm regards,
